Human Gene Therapy: A Biopolitical Overview and Analysis
Author:
- 1 April 1993
- journal article
- Published by SAGE Publications in Human Gene Therapy
- Vol. 4 (2) , 187-193
Abstract
The benefits, risks, and social consequences arising from human gene therapy have received substantial citation in the literatures of medical, biological, ethical, and legal commentary. I argue that the question of what "public policy garb" best fits the parameters of human gene therapy in the United States and around the world is a quintessential political question, best understood under the microscope of political science analytic inquiry. I describe the nature of that inquiry, apply its insights to the various ends and means of human gene therapy, and posit empirical models of "political success" for the salient purposes of the craft. I focus particularly on the tract record of the National Institutes of Health's Recombinant DNA Advisory Committee (RAC) in orchestrating the process by which human gene therapy protocols achieve official sanction.Keywords
This publication has 17 references indexed in Scilit:
- Back to the Drawing Board, Says NIHScience, 1992
- NIH to Size Up Growth Hormone TrialsScience, 1992
- Fetal Tissue ResearchScience, 1992
- Germ-line Gene Therapy: A New Stage of DebateLaw, Medicine and Health Care, 1992
- The NIH “Points to Consider” and the Limits of Human Gene TherapyHuman Gene Therapy, 1990
- Human Gene Therapy and CongressHuman Gene Therapy, 1990
- Legal Regulation of Human Gene TherapyHuman Gene Therapy, 1990
- Human Gene Therapy: Must We Know Where to Stop Before We Start?Human Gene Therapy, 1990
- The Impact of the Report, Splicing LifeHuman Gene Therapy, 1990
- Human Gene Therapy, the Public, and Public PolicyHuman Gene Therapy, 1990